The Premarin Class Action Lawsuit involves a class of plaintiffs that were injured by Premarin, Proscar, or Prempro between January 1995 and February 2021, who are neither claiming any medical injury as a result of the drugs nor are claiming any damages for personal injuries as a result of the drugs. In February 2021, after the passage of a law requiring mandatory notification of all manufacturers of prescription drugs, the manufacturers of Premarin, Proscar, and other similar antidepressants received a letter from the state of California stating that they must now notify all California users of their potential risks posed by the drug’s use. As a result, many lawsuits have been filed against the manufacturers. Some of these suits have been resolved by the courts, while others have been put on hold until further notice. If you are one of the people who have received a lawsuit notice and believe that you may be entitled to compensation under the law, it is important to understand that such lawsuits cannot be brought against the manufacturer of the drug itself. A personal injury lawsuit that is brought against a manufacturer of the drug that has manufactured the drug that caused the injury is called a product liability lawsuit.
This article will focus on one of the more famous class action lawsuits concerning Premarin. The class-action lawsuit was brought against GlaxoSmithKline, the maker of Premarin. GlaxoSmithKline marketed Premarin as a safe over-the-counter sleep aid, but when people began to experience sleeplessness after taking the drug, GlaxoSmithKline became the focus of the lawsuit because it did not act responsibly in providing information about the dangers of the drug to consumers. As a result of this negligence, a large number of plaintiffs were able to receive significant monetary compensation from GlaxoSmithKline.
Premarin was marketed by GlaxoSmithKline as a sleep aid that provided benefits such as preventing jet lag and suppressing body odor. But as the defendant’s counsel continued to market Premarin throughout the fall and into the winter months, there was a clear pattern to what should have been a simple class action lawsuit: people would begin reporting weird things like excessive sleepiness and body odors. By failing to provide adequate warnings about the potential dangers of taking Premarin, GlaxoSmithKline was responsible for thousands of class action lawsuits arising from those who used Premarin and suffered injuries from its use. As a result of the widespread publicity surrounding Premarin, GlaxoSmithKline was forced to file a $b Billion settlement against the distributors of the drug. As a result of this settlement, GlaxoSmithKline was ordered to pay claims to innocent Class Action victims and to pay medical expenses and other monetary losses that resulted from their wrongful acts.
This is just one of the many class-action lawsuits that have resulted from the dangerous use of prescription drugs like Premarin. GlaxoSmithKline was one of the pharmaceutical companies involved in a number of these class action lawsuits that received huge payouts to cover their irresponsible actions. These financial corporations were able to Dodge millions of dollars in liabilities by choosing to settle rather than go to trial, which resulted in many Class Action lawsuits being initiated and won by actual victims of the dangerous products sold by GlaxoSmithKline.
The pharmaceutical company was also deeply involved in another scandal regarding the use of unapproved ingredients in GlaxoSmithKline’s transition estrogen Premarin replacement product. Several people became extremely ill after using the product, and there have been numerous reports of organ toxicity, nervous system damage, strokes, convulsions, respiratory failure, allergic reactions, allergic skin rash, depression, anxiety, erratic behavior, high blood pressure, heart failure, pancreas failure, liver disease, coma, and death. The actual name of the substance within the medication is “trenbolone acetate”, which has since been changed to “Teofilo”. To avoid any more lawsuits, GlaxoSmithKline has offered to settle all claims within three years of the date of the lawsuit. This offer does not include any out-of-pocket expenses that may be assessed by the courts and attorneys.
A common problem with Premarin replacement therapy is that the cream itself is applied directly to the external surface of the vagina. Because this application exposes the body to harmful chemicals and contaminants, it is essential that the cream is kept away from the body at all times, even during its intended use. There have been recent reports of a new cream called “Preventative Pemolin” which prevents the absorption of tranitazine, an extremely dangerous ingredient contained in Premarin cream. This new cream has not undergone any official clinical testing and is yet to receive approval by the FDA.
